13C-Methacetin

DRUG2 trials

Sponsors

Virginia Commonwealth University, University of Texas Southwestern Medical Center

Conditions

Acute Liver FailureCirrhosisFatty Liver

Phase 2

13C-Methacetin Breath Test for the Prediction of Outcome in in ALI or ALF

CompletedNCT02786836

University of Texas Southwestern Medical CenterAcute Liver Failure

Start: 2016-06-10End: 2019-09-18Updated: 2020-12-22

Phase 3

Development of a Breath Test for Monitoring Patients With Liver Disease

CompletedNCT00244569

Virginia Commonwealth UniversityCirrhosis, Fatty Liver

Start: 2005-09-30End: 2007-04-30Target: 120Updated: 2017-03-20